Asfertglobal launches Kiplant Metacare - a technological biofungicide for Botrytis cinerea, Stemphylium spp. and Monilia spp. control
Asfertglobal strengthens its portfolio of biotechnological solutions with Kiplant Metacare launch, an innovative foliar biofungicide that ensures effective control of Botrytis cinerea, Stemphylium spp. and other diseases that affect high value crops.
Authorized for sale in Portugal and Spain and expected to expand to new markets soon, Kiplant Metacare is a safe and effective solution for fighting pathogenic fungi, reinforcing Asfertglobal's commitment to biotechnological innovation and sustainability.
Unlike conventional fungicides, Kiplant Metacare is biologically based, formulated with Bacillus amyloliquefaciens AH2, a strain naturally present in the soil. Its exclusive formulation preserves the stability of the microorganisms, ensuring high persistence and maximising efficacy in the field.
Kiplant Metacare has a multifunctional mode of action, based on three main mechanisms:
• Protective colonization of plant tissues: Forms a physical barrier in plant tissues and prevents pathogens from establishing themselves by competing for space and essential nutrients.
• Production of active metabolites: Produces biocidal compounds that inhibit the growth and spread of fungi and bacteria.
• Activation of natural defenses: Activates the plant's natural defense mechanisms by inducing the salicylic acid and jasmonic acid cycles, increasing plant resistance against pathogens.
This launch reinforces Asfertglobal's commitment to providing innovative, sustainable and highly effective solutions for crop protection, promoting a more balanced and environmentally responsible agriculture.
